Home > News > Headline News > Archive

Click on title to read the full article.

Gefitinib improves progression-free survival in metastatic breast cancer

March 26, 2010

By CureToday.com

NEW YORK (Reuters Health) - Adding the epidermal growth factor receptor (EGFR) inhibitor gefitinib to anastrozole improves progression-free survival in postmenopausal women with hormone receptor-positive metastatic breast cancer, new research shows.

EBCC: Targeted Therapy Boosts Metastatic Breast Cancer Survival

March 25, 2010

By Charles Bankhead, Staff Writer, MedPage Today

BARCELONA — Progression-free survival in metastatic breast cancer improved by almost a third in women who received bevacizumab (Avastin) in addition to chemotherapy as first-line treatment, a meta-analysis of clinical trials showed.

What should be the goal of treatment in metastatic breast cancer?

March 24, 2010

By www.rdmag.com

Barcelona, Spain: Many patients with metastatic breast cancer believe that the primary goal in survival with new treatment should be to prolong life by at least a year over the survival they might expect from using current best therapies, a researcher will tell the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Wednesday). This finding contrasts with doctors’ perception that an additional four to six months’ survival is significant enough to consider a new treatment worthwhile.

‘Microtentacles’ on tumor cells appear to play role in how breast cancer spreads

March 12, 2010

By University of Maryland Medical Center

While twisted remnants of tau protein have been seen in the brain tissue of patients with Alzheimer’s disease, this is the first report that tau could play a role in tumor metastasis by changing the shape of cancer cells.

Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18

March 10, 2010

By Indiana University

Although fulvestrant has been used to treat cancer since the late 1980s, and is now commonly prescribed as a second-line defense against metastatic cancer cells, how the drug works is still not completely understood.

The Side-Out Foundation Hopes to Score Big with Its First Funded Breast Cancer Clinical Trial

March 9, 2010

By PR Newswire

The Side-Out Foundation, which pairs volleyball enthusiasts with breast cancer researchers, is sponsoring a new clinical trial for up to 25 patients with advanced breast cancer.

The Heart: An Unintended Victim of Some Targeted Cancer Therapies

March 9, 2010

By National Cancer Institute

Among the targeted agents, the monoclonal antibody trastuzumab (Herceptin), which is used in women with both metastatic and early-stage breast cancer, has probably received the most attention for its cardiotoxicit

Hypnosis Can Help Control Pain Among Women with Metastatic Breast Cancer, UB Researcher Finds

March 1, 2010

By University of Buffalo

BUFFALO, N.Y. — Hypnosis can help alleviate the pain and suffering experienced by women being treated for breast cancer, according to a study by a University at Buffalo School of Social Work professor